Borviz 2.5 Injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Borviz 2.5 Injection

Borviz 2.5 Injection

Borviz 2.5 Injection contains bortezomib 2.5 mg and is a proteasome inhibitor used as an anticancer medicine. It is mainly used for the treatment of multiple myeloma and mantle cell lymphoma. The injection is administered by a qualified healthcare professional under specialist medical supervision.

BUY NOW

Category

Bortezomib blocks proteasomes, structures that help cells break down unwanted proteins, causing abnormal protein accumulation that can lead to cancer-cell death. It may be used alone or with other medicines depending on the cancer type and prescribed treatment protocol. Blood counts and other clinical parameters are monitored during treatment because therapy may cause low blood-cell counts, infections, gastrointestinal effects, and peripheral neuropathy. The dose and administration schedule are individualized by the treating oncologist according to the patient’s condition and treatment response.

Technical Specification

Specification Details
Active Ingredient Bortezomib
Strength 2.5 mg
Dosage Form Injection
Pack Size 1 Vial
Route of Administration Intravenous or Subcutaneous
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Borviz 2.5mg Injection, Borviz 2.5 mg Injection, Bortezomib 2.5mg Injection, Bortezomib 2.5 mg Injection, Bortezomib 2.5mg Vial, Bortezomib Oncology Injection